• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颗粒大小、气流及吸入装置对色甘酸钠粉末雾化的影响。

Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.

作者信息

Chew N Y, Bagster D F, Chan H K

机构信息

Faculty of Pharmacy, University of Sydney, A15, NSW 2006, Sydney, Australia.

出版信息

Int J Pharm. 2000 Sep 25;206(1-2):75-83. doi: 10.1016/s0378-5173(00)00516-0.

DOI:10.1016/s0378-5173(00)00516-0
PMID:11058812
Abstract

Recently, the dispersion of mannitol powders has demonstrated the importance of particle size, air flow and inhaler device (Chew and Chan, 1999). The aim of the present study is to extend our investigation to a different compound, disodium cromoglycate (DSCG) powders. Solid state characteristics of the powders were assessed by particle sizing, scanning electron microscopy, X-ray powder diffraction, moisture content, particle density determination and freeze fracture. The aerosol behaviour of the powders was studied by dispersion using Rotahaler(R) and Dinkihaler(R), connected to a four-stage liquid impinger operating at 30-120 l/min. Three amorphous powders with a mass median diameter (MMD) of 2.3, 3.7, 5.2 microm and a similar polydispersity were prepared. The particles were nearly spherical with a particle density of 1.6 g/cm(3) and moisture content of 6.6 wt.%. Using Rotahaler(R), the maximum fine particle fraction (FPF(max)) for all three powders was only 15 wt.%, attained at the highest flow of 120 l/min. Using Dinkihaler(R), the FPF(max) was two to four times higher, being 36 and 29 wt.% for the 2.3 and 3.7 microm powder, respectively, at 60 l/min; and 18 wt.% for the 5.2 microm powder at 120 l/min. Hence, the study shows that the FPF in the DSCG powder aerosols was determined by the interaction of the particle size, air flow and inhaler design. The attribution of the amorphous nature and the different physico-chemical properties of the powder may explain the incomplete and low dispersibility of DSCG.

摘要

最近,甘露醇粉末的分散情况已表明粒径、气流和吸入装置的重要性(Chew和Chan,1999年)。本研究的目的是将我们的调查扩展到另一种化合物——色甘酸钠(DSCG)粉末。通过粒径分析、扫描电子显微镜、X射线粉末衍射、水分含量、颗粒密度测定和冷冻断裂来评估粉末的固态特性。使用与以30 - 120升/分钟运行的四级液体冲击器相连的Rotahaler®和Dinkihaler®通过分散来研究粉末的气溶胶行为。制备了三种质量中值直径(MMD)分别为2.3、3.7、5.2微米且多分散性相似的无定形粉末。颗粒近乎球形,颗粒密度为1.6克/立方厘米,水分含量为6.6重量%。使用Rotahaler®时,所有三种粉末的最大细颗粒分数(FPF(max))仅为15重量%,在120升/分钟的最高流速下达到。使用Dinkihaler®时,FPF(max)高出两到四倍,对于2.3微米和3.7微米的粉末,在60升/分钟时分别为36重量%和29重量%;对于5.2微米的粉末,在120升/分钟时为18重量%。因此,该研究表明DSCG粉末气溶胶中的FPF由粒径、气流和吸入器设计的相互作用决定。粉末的无定形性质以及不同的物理化学性质可能解释了DSCG不完全且低分散性的原因。

相似文献

1
Effect of particle size, air flow and inhaler device on the aerosolisation of disodium cromoglycate powders.颗粒大小、气流及吸入装置对色甘酸钠粉末雾化的影响。
Int J Pharm. 2000 Sep 25;206(1-2):75-83. doi: 10.1016/s0378-5173(00)00516-0.
2
Influence of particle size, air flow, and inhaler device on the dispersion of mannitol powders as aerosols.颗粒大小、气流及吸入装置对甘露醇粉末作为气雾剂分散的影响。
Pharm Res. 1999 Jul;16(7):1098-103. doi: 10.1023/a:1018952203687.
3
Use of solid corrugated particles to enhance powder aerosol performance.使用固体波纹颗粒增强粉末气溶胶性能。
Pharm Res. 2001 Nov;18(11):1570-7. doi: 10.1023/a:1013082531394.
4
Effect of amino acids on the dispersion of disodium cromoglycate powders.氨基酸对色甘酸钠粉末分散性的影响。
J Pharm Sci. 2005 Oct;94(10):2289-300. doi: 10.1002/jps.20426.
5
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.用标准夹带管从含有一水乳糖的药物混合物中产生的干粉气雾剂:1. 硫酸沙丁胺醇和二钠色甘酸钠。
J Pharm Sci. 2010 Aug;99(8):3398-414. doi: 10.1002/jps.22107.
6
Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.硬脂酸钠对吸湿性喷雾干燥粉末水致劣化的保护作用。
Int J Pharm. 2018 Apr 25;541(1-2):11-18. doi: 10.1016/j.ijpharm.2018.02.018. Epub 2018 Feb 15.
7
The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.载体对单独喷雾干燥或与L-亮氨酸一起喷雾干燥的色甘酸钠微粒的物理性质和气溶胶化行为的影响。
Int J Pharm. 2004 Nov 5;285(1-2):97-108. doi: 10.1016/j.ijpharm.2004.07.027.
8
In-situ-micronization of disodium cromoglycate for pulmonary delivery.用于肺部给药的色甘酸钠原位微粉化
Eur J Pharm Biopharm. 2003 Mar;55(2):173-80. doi: 10.1016/s0939-6411(02)00168-6.
9
Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.保护疏水性氨基酸,防止高吸湿性喷雾干燥粉末的雾化性能因水分引起的劣化。
Eur J Pharm Biopharm. 2017 Oct;119:224-234. doi: 10.1016/j.ejpb.2017.06.023. Epub 2017 Jun 24.
10
Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery.
Pharm Res. 1997 Apr;14(4):431-7. doi: 10.1023/a:1012035113276.

引用本文的文献

1
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.
2
Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches.工程化可吸入治疗颗粒:传统方法与新兴方法
Pharmaceutics. 2023 Nov 30;15(12):2706. doi: 10.3390/pharmaceutics15122706.
3
Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis.用于囊性纤维化肺部给药的干粉吸入法
Pharmaceutics. 2023 May 13;15(5):1488. doi: 10.3390/pharmaceutics15051488.
4
Advancements in Particle Engineering for Inhalation Delivery of Small Molecules and Biotherapeutics.粒子工程技术在小分子和生物治疗吸入递送上的进展。
Pharm Res. 2022 Dec;39(12):3047-3061. doi: 10.1007/s11095-022-03363-2. Epub 2022 Sep 7.
5
Dry Powder for Pulmonary Delivery: A Comprehensive Review.肺部给药干粉剂:全面综述
Pharmaceutics. 2020 Dec 28;13(1):31. doi: 10.3390/pharmaceutics13010031.
6
Effects of Moisture-Induced Crystallization on the Aerosol Performance of Spray Dried Amorphous Ciprofloxacin Powder Formulations.水分诱导结晶对喷雾干燥无定形环丙沙星粉末制剂气溶胶性能的影响。
Pharm Res. 2018 Jan 2;35(1):7. doi: 10.1007/s11095-017-2281-5.
7
Multi-scale modelling of powder dispersion in a carrier-based inhalation system.基于载体的吸入系统中粉末分散的多尺度建模
Pharm Res. 2015 Jun;32(6):2086-96. doi: 10.1007/s11095-014-1601-2. Epub 2014 Dec 17.
8
Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties.微粉化材料中粉末亚群存在的证据:雾化粉末的空气动力学粒径级分具有独特的物理化学性质。
Pharm Res. 2014 Dec;31(12):3251-64. doi: 10.1007/s11095-014-1414-3.
9
Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.粒状乳糖作为干粉吸入剂制剂载体的评价1:颗粒大小的影响。
AAPS PharmSciTech. 2014 Dec;15(6):1417-28. doi: 10.1208/s12249-014-0166-z. Epub 2014 Jun 25.
10
Investigation into alternative sugars as potential carriers for dry powder formulation of budesonide.探讨替代糖作为布地奈德干粉制剂潜在载体的研究。
Bioimpacts. 2011;1(2):105-11. doi: 10.5681/bi.2011.014. Epub 2011 Aug 5.